No headlines found.
Globe Newswire (Wed, 21-Jan 4:30 PM ET)
Masimo Announces Select Preliminary 2025 Financial Results
Business Wire (Mon, 12-Jan 9:00 AM ET)
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
Business Wire (Wed, 7-Jan 9:00 AM ET)
PRNewswire (Fri, 5-Dec 3:20 PM ET)
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
Business Wire (Wed, 3-Dec 4:10 PM ET)
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
PRNewswire (Tue, 18-Nov 9:00 AM ET)
Business Wire (Fri, 14-Nov 8:55 PM ET)
Business Wire (Thu, 13-Nov 9:49 AM ET)
Masimo Reports Third Quarter 2025 Results
Business Wire (Tue, 4-Nov 4:05 PM ET)
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Masimo trades on the NASDAQ stock market under the symbol MASI.
As of January 28, 2026, MASI stock price declined to $137.67 with 1,101,003 million shares trading.
MASI has a beta of 1.01, meaning it tends to be more sensitive to market movements. MASI has a correlation of 0.24 to the broad based SPY ETF.
MASI has a market cap of $7.44 billion. This is considered a Mid Cap stock.
Last quarter Masimo reported $371 million in Revenue and $1.32 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.12.
In the last 3 years, MASI traded as high as $198.00 and as low as $75.22.
The top ETF exchange traded funds that MASI belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
MASI has underperformed the market in the last year with a return of -19.3%, while the SPY ETF gained +17.2%. In the last 3 month period, MASI fell short of the market, returning -7.0%, while SPY returned +1.8%. However, in the most recent 2 weeks MASI has outperformed the stock market by returning +6.0%, while SPY returned +0.2%.
MASI support price is $134.23 and resistance is $141.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MASI shares will trade within this expected range on the day.